328 related articles for article (PubMed ID: 8805148)
21. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas.
Black KL; Cloughesy T; Huang SC; Gobin YP; Zhou Y; Grous J; Nelson G; Farahani K; Hoh CK; Phelps M
J Neurosurg; 1997 Apr; 86(4):603-9. PubMed ID: 9120622
[TBL] [Abstract][Full Text] [Related]
22. Cyclic GMP-specific phosphodiesterase inhibition and intracarotid bradykinin infusion enhances permeability into brain tumors.
Sugita M; Black KL
Cancer Res; 1998 Mar; 58(5):914-20. PubMed ID: 9500450
[TBL] [Abstract][Full Text] [Related]
23. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
[TBL] [Abstract][Full Text] [Related]
24. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas.
Matsukado K; Sugita M; Black KL
Brain Res; 1998 May; 792(1):10-5. PubMed ID: 9593802
[TBL] [Abstract][Full Text] [Related]
25. Intravenous cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain.
Emerich DF; Dean RL; Marsh J; Pink M; Lafreniere D; Snodgrass P; Bartus RT
Pharm Res; 2000 Oct; 17(10):1212-9. PubMed ID: 11145226
[TBL] [Abstract][Full Text] [Related]
26. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.
Emerich DF; Dean RL; Osborn C; Bartus RT
Clin Pharmacokinet; 2001; 40(2):105-23. PubMed ID: 11286321
[TBL] [Abstract][Full Text] [Related]
27. Selective opening of the blood-tumor barrier by intracarotid infusion of leukotriene C4.
Black KL; King WA; Ikezaki K
J Neurosurg; 1990 Jun; 72(6):912-6. PubMed ID: 2338576
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma.
Prados MD; Schold SC; Fine HA; Jaeckle K; Hochberg F; Mechtler L; Fetell MR; Phuphanich S; Feun L; Janus TJ; Ford K; Graney W
Neuro Oncol; 2003 Apr; 5(2):96-103. PubMed ID: 12672281
[TBL] [Abstract][Full Text] [Related]
29. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
30. Selective opening of the blood-tumour barrier by intracarotid infusion of leukotriene C4.
Black KL; King WA; Ikezaki K
Acta Neurochir Suppl (Wien); 1990; 51():140-1. PubMed ID: 1982476
[TBL] [Abstract][Full Text] [Related]
31. Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures.
Qureshi AI; Suri MF; Khan J; Sharma M; Olson K; Guterman LR; Hopkins LN
J Neurooncol; 2001 Jan; 51(2):151-8. PubMed ID: 11386412
[TBL] [Abstract][Full Text] [Related]
32. The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas.
Nakagawa H; Groothuis D; Blasberg RG
Neurology; 1984 Dec; 34(12):1571-81. PubMed ID: 6504329
[TBL] [Abstract][Full Text] [Related]
33. Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas.
Cloughesy TF; Black KL; Gobin YP; Farahani K; Nelson G; Villablanca P; Kabbinavar F; Viñeula F; Wortel CH
Neurosurgery; 1999 Feb; 44(2):270-8; discussion 278-9. PubMed ID: 9932880
[TBL] [Abstract][Full Text] [Related]
34. Capillary permeability in experimental rat glioma and effects of intracarotid CDDP administration on tumor drug delivery.
Ichimura K; Ohno K; Aoyagi M; Tamaki M; Suzuki R; Hirakawa K
J Neurooncol; 1993 Jun; 16(3):211-5. PubMed ID: 8301345
[TBL] [Abstract][Full Text] [Related]
35. Increased delivery of a new cisplatin analogue (254-S) in a rat brain tumor by an intracarotid infusion of bradykinin.
Koga H; Inamura T; Ikezaki K; Nomura T; Samoto K; Fukui M
Neurol Res; 1996 Jun; 18(3):244-7. PubMed ID: 8837061
[TBL] [Abstract][Full Text] [Related]
36. Selective blood-tumor barrier disruption by leukotrienes.
Chio CC; Baba T; Black KL
J Neurosurg; 1992 Sep; 77(3):407-10. PubMed ID: 1506887
[TBL] [Abstract][Full Text] [Related]
37. Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life.
Sarin H; Kanevsky AS; Fung SH; Butman JA; Cox RW; Glen D; Reynolds R; Auh S
J Transl Med; 2009 May; 7():33. PubMed ID: 19439100
[TBL] [Abstract][Full Text] [Related]
38. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
[TBL] [Abstract][Full Text] [Related]
39. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
40. Intracarotid RMP-7 enhanced indocyanine green staining of tumors in a rat glioma model.
Britz GW; Ghatan S; Spence AM; Berger MS
J Neurooncol; 2002 Feb; 56(3):227-32. PubMed ID: 12061728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
